Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.

MLA

Wu, Q., et al. Reduced Mortality and Subsequent Fracture Risk Associated with Oral Bisphosphonate Recommendation in a Fracture Liaison Service Setting: A Prospective Cohort Study. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1382615157&authtype=sso&custid=ns315887.

APA

Wu, Q., van Geel, T., Bliuc, D., Geusens, P., Center, J., Dinant, G.-J., Tran, T., van den Bergh, J., McLellan, A., & Eisman, J. (2018). Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: A prospective cohort study.

Chicago

Wu, Q, Tacm van Geel, D Bliuc, Ppm Geusens, Jr Center, G-J Dinant, T Tran, Jpw van den Bergh, Ar McLellan, and Ja Eisman. 2018. “Reduced Mortality and Subsequent Fracture Risk Associated with Oral Bisphosphonate Recommendation in a Fracture Liaison Service Setting: A Prospective Cohort Study.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1382615157&authtype=sso&custid=ns315887.